Bone Marrow Transplant
Antigens, CD19Biological ProductsCytokine Release Syndrome
Dr. Muhamed Baljevic, MD
NPI1740507706PAC ID1355633496
- Medicare services, 2024
- 817
- Medicare patients, 2024
- 299
- Part D claims, 2024
- 625
- Publications
- 30
- Clinical trials
- 3
- Practice address
- 1211 Medical Center Drive, Nashville, TN 37232
- Practice phone
- Call (615) 322-3454
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Baljevic's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Muhamed Baljevic is a hematologist and oncologist in Nashville, Tennessee
Dr. Baljevic practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.
Dr. Baljevic's NPI, 1740507706, was assigned on April 29, 2010. Dr. Baljevic holds Tennessee license 64144.
NPI and contact details
- NPI
- 1740507706NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1355633496
- NPI enumeration date
- April 29, 2010
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (615) 322-3454
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 42
- Medical school graduation
- 2010
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Muhamed Baljevic practices at Vanderbilt University Medical Center in Nashville, Tennessee
Dr. Baljevic's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.
- Vanderbilt University Medical Center1211 Medical Center Drive, Nashville, TN 37232 · Davidson CountyPhone(615) 322-3454
Source: Dmand AI Affiliation Data
Dr. Muhamed Baljevic is affiliated with 5 sites of care and 2 medical groups
Dr. Baljevic's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Baljevic is also affiliated with Vanderbilt Wilson County Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Baljevic to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.
Vanderbilt Wilson County HospitalVanderbilt University Medical Center2 group practices and clinicsNames with a free account1 home health agencyName with a free account1 medical groupName with a free account
See all 7 affiliations for Dr. BaljevicSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Muhamed Baljevic's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baljevic practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Vanderbilt University Medical Center | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Baljevic practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Vanderbilt University Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Muhamed Baljevic is one of 271 hematologists and oncologists in Tennessee
Hematology and oncology is Dr. Baljevic's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Baljevic's licenses on file in 2 states: Tennessee and Nebraska.
Specialties and state licenses
- Hematology and oncology, TennesseePrimary
- Family medicine, Nebraska
Hematologists and oncologists near Dr. Baljevic
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
271hematologists and oncologists in Tennessee66hematologists and oncologists in Nashville44hematologists and oncologists at Vanderbilt University Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Muhamed Baljevic billed Medicare for 817 services in 2024
CMS data shows 817 Medicare services from Dr. Baljevic across 8 procedure codes in 2024, for 299 Medicare patients. Medicare paid $74,371 for them.
Medicare services, 2024817
Medicare patients299
Paid by Medicare$74,371
Procedure codes8
Dr. Baljevic's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8062024: 7932%
- Other services
- 2023: 02024: 24
Where Dr. Baljevic's Medicare services took place, 2024
- In an office638%
- In a facility75492%
Dr. Baljevic compared with the Tennessee median for hematologists and oncologists, 2024
- Dr. Baljevic
- Tennessee median
- Medicare services
- 817vs 818Close to median
- Medicare patients
- 299vs 287Close to median
- Part D claims
- 517vs 508Close to median
Medians across 259 hematologists and oncologists in Tennessee with Dmand AI profiles that report each measure.
Dr. Baljevic's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Baljevic?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Baljevic and other hematologists and oncologists in Tennessee.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Muhamed Baljevic treated 299 Medicare patients in 2024, average age 72
CMS counts 299 Medicare patients who saw Dr. Baljevic in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Baljevic's median patient age at 74, with 50% women.
Medicare patients, 2024299
Average age72
Average risk score2.81
Dr. Baljevic's Medicare patients by age, 2024
Dr. Baljevic's Medicare patients by sex, 2024
- Women14749%
- Men15251%
Chronic conditions among Dr. Baljevic's Medicare patients, 2024
- High blood pressure75%
- High cholesterol71%
- Arthritis49%
- Chronic kidney disease45%
- Ischemic heart disease40%
- Heart failure33%
- Anxiety32%
- Mood disorders31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Baljevic's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women50%
- Men50%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Muhamed Baljevic wrote 625 Medicare Part D claims in 2024
In 2024, Dr. Baljevic wrote 625 Medicare Part D claims for 91 patients. 68% of them were for generic drugs. CMS names the drug for 517 of them, across 12 drugs with 11 or more claims each, at $3,603,333 in total drug cost. In 2023, CMS named 383 claims across 9 drugs.
Part D claims, 2024625
Drugs named by CMS12
Total drug cost$3.6M
Part D patients91
Dr. Baljevic's Part D claims by kind of drug, 2024
- Generic423 claims68%
- Brand-name and other202 claims32%
Dr. Baljevic's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Baljevic's Part D claims, 2024
- Antibiotics6%40 of 625 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3832024: 51735%
Drugs named by CMS: 12 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Muhamed Baljevic offers telehealth to Medicare patients
Dr. Baljevic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baljevic as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Baljevic by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Muhamed Baljevic has 30 publications on record
Dmand AI links 30 papers to Dr. Baljevic, published from 2012 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Multiple Myeloma, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Baljevic has published most often in Bone Marrow Transplant. Dr. Baljevic's most frequent co-authors are Natalie S. Callander, MD, William Ira Bensinger, MD and Noa Biran, MD.
Papers30
Years published2012 to 2025
Dr. Baljevic's papers by year, 2012 to 2025
Topics Dr. Baljevic writes about most
- Multiple Myeloma
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Hematopoietic Stem Cell Transplantation
- Proteasome Inhibitors
- Bortezomib
- Cell Line, Tumor
- Dexamethasone
Dr. Baljevic's most frequent co-authors
- Natalie S. Callander, MD6 shared papers
- William Ira Bensinger, MD3 shared papers
- Noa Biran, MD3 shared papers
Recent publications by Dr. Baljevic
Blood Cancer J
Antineoplastic Combined Chemotherapy ProtocolsMultiple Myeloma
Bone Marrow Transplant
AmyloidosisImmunoglobulin Light-chain AmyloidosisImmunoglobulin Light Chains
See who Dr. Baljevic researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Baljevic works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Muhamed Baljevic has worked on 3 clinical trials
Dmand AI links Dr. Baljevic to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Open Payments lists research payments to Dr. Baljevic that name 1 trial.
Clinical trials with Dr. Baljevic by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Baljevic's trials
- Multiple Myeloma
- Blood Protein Disorders
Investigators on the most trials with Dr. Baljevic
Recent clinical trials with Dr. Baljevic
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation (opens in a new tab)
TerminatedPhase 2
Multiple MyelomaBlood Protein DisordersMelphalanT Cell-Depleted Hematopoietic Stem Cell TransplantationTetanus Toxoid Vaccine
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (opens in a new tab)
Active, not recruitingPhase 3
Multiple MyelomaBlood Protein DisordersBortezomibCarfilzomibDexamethasone
Selinexor and Backbone Treatments of Multiple Myeloma Patients (opens in a new tab)
RecruitingPhase 1/2
Multiple MyelomaBlood Protein DisordersSelinexorBelantamab MafodotinBortezomib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Muhamed Baljevic received $341,384 in industry payments from 2017 to 2025
CMS Open Payments shows 190 general payments to Dr. Baljevic from 22 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 93% of the total. GlaxoSmithKline, LLC. paid the most, $197,750. It also lists 13 research payments totaling $38,047 from 2020 to 2025, naming 1 clinical trial.
General payments to Dr. Baljevic by program year, 2017 to 2025
General payments to Dr. Baljevic by kind, 2017 to 2025
$341.4Kin total
- Consulting fees$317,84493%
- Travel and lodging$12,3724%
- Food and beverage$8,1512%
- Speaker and faculty fees$2,5481%
- Other$4690%
Companies that paid Dr. Baljevic the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Muhamed Baljevic's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Muhamed Baljevic
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Muhamed Baljevic's NPI number?
Dr. Muhamed Baljevic's NPI number is 1740507706. It was assigned on April 29, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Muhamed Baljevic?
Dr. Muhamed Baljevic is a hematologist and oncologist in Nashville, Tennessee. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Muhamed Baljevic practice?
Dr. Baljevic practices at 1211 Medical Center Drive, Nashville, TN 37232. Dr. Baljevic's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dmand AI also links Dr. Baljevic to 2 group practices and clinics, 1 home health agency and 1 medical group.
What is Dr. Muhamed Baljevic's office phone number?
The practice phone on file for Dr. Baljevic is (615) 322-3454.
What is Dr. Muhamed Baljevic's medical license number?
Dr. Baljevic holds Tennessee license 64144, one of the licenses on file in 2 states.
Which states has Dr. Muhamed Baljevic been licensed in?
Dmand AI has state licenses on file for Dr. Baljevic in Tennessee and Nebraska.
Which hospitals is Dr. Muhamed Baljevic affiliated with?
Dr. Baljevic practices at Vanderbilt University Medical Center in Nashville, Tennessee. Dr. Baljevic is also affiliated with Vanderbilt Wilson County Hospital.
What medical group is Dr. Muhamed Baljevic part of?
Dr. Baljevic is linked to Vanderbilt University Medical Center. Dmand AI links Dr. Baljevic to 1 more medical group.
Does Dr. Muhamed Baljevic accept Medicare?
Yes. CMS data shows Dr. Baljevic billed Medicare for 817 services in 2024, and Dr. Baljevic accepts Medicare assignment.
Does Dr. Muhamed Baljevic offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Baljevic as offering telehealth services.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Muhamed Baljevic see?
CMS counts 299 Medicare patients who saw Dr. Baljevic in 2024, with an average age of 72.
What services does Dr. Muhamed Baljevic bill to Medicare?
In 2024, Dr. Baljevic's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99233) and hospital inpatient care (99232).
What drugs does Dr. Muhamed Baljevic prescribe most?
In 2024 Medicare Part D data, Dr. Baljevic's most prescribed drugs by claims were Valacyclovir, Revlimid and Gabapentin.
Has Dr. Muhamed Baljevic received payments from drug or device companies?
CMS Open Payments shows $341,384 in general payments to Dr. Baljevic from 22 companies from 2017 to 2025. The largest total came from GlaxoSmithKline, LLC.
How long has Dr. Muhamed Baljevic been practicing?
Dr. Baljevic graduated from medical school in 2010, 16 years ago.
Does Dr. Muhamed Baljevic do research?
Dmand AI links 30 publications to Dr. Baljevic, published from 2012 to 2025. Dr. Baljevic has worked on 3 clinical trials.
Who does Dr. Muhamed Baljevic publish with?
Dr. Baljevic's most frequent co-authors are Natalie S. Callander, MD (6 shared papers), William Ira Bensinger, MD (3 shared papers) and Noa Biran, MD (3 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card